048410.KQ
Hyundai Bioscience Co., Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 6,050.00
−0.49%Margins
Gross margin
-21.2%
EBITDA margin
-537.3%
EBIT margin
-580.1%
Net margin
-796.6%
FCF margin
-532.0%
-25.6%
Return on equity
-20.1%
Return on assets
-15.3%
Return on invested capital
0.03x
Asset turnover
-KRW 16.7B
Cash from operations
KRW 436
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026